CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 82 filers reported holding CALITHERA BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $24,000 | -51.0% | 9,723 | -2.8% | 0.00% | – |
| Q4 2020 | $49,000 | +44.1% | 10,003 | 0.0% | 0.00% | – |
| Q3 2020 | $34,000 | -50.0% | 10,003 | -22.4% | 0.00% | – |
| Q2 2020 | $68,000 | +112.5% | 12,898 | +79.7% | 0.00% | – |
| Q1 2020 | $32,000 | -30.4% | 7,178 | -11.1% | 0.00% | – |
| Q4 2019 | $46,000 | +91.7% | 8,077 | +3.3% | 0.00% | – |
| Q3 2019 | $24,000 | +14.3% | 7,818 | +42.4% | 0.00% | – |
| Q2 2019 | $21,000 | -43.2% | 5,491 | 0.0% | 0.00% | – |
| Q1 2019 | $37,000 | +68.2% | 5,491 | 0.0% | 0.00% | – |
| Q4 2018 | $22,000 | +4.8% | 5,491 | +37.6% | 0.00% | – |
| Q3 2018 | $21,000 | +5.0% | 3,991 | 0.0% | 0.00% | – |
| Q2 2018 | $20,000 | -41.2% | 3,991 | -26.5% | 0.00% | – |
| Q1 2018 | $34,000 | -46.9% | 5,432 | -28.9% | 0.00% | – |
| Q4 2017 | $64,000 | -49.2% | 7,637 | -5.0% | 0.00% | – |
| Q3 2017 | $126,000 | +5.0% | 8,041 | -0.7% | 0.00% | – |
| Q2 2017 | $120,000 | – | 8,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $3,623,000 | 1.38% |
| Atika Capital Management LLC | 260,000 | $3,861,000 | 1.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 497,691 | $7,390,000 | 0.54% |
| ASCEND CAPITAL, LLC | 413,606 | $6,143,000 | 0.29% |
| VIKING GLOBAL INVESTORS LP | 2,420,317 | $35,942,000 | 0.24% |
| EAM Investors, LLC | 84,668 | $1,257,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,122,873 | $61,225,000 | 0.15% |
| Schonfeld Strategic Advisors LLC | 75,000 | $1,114,000 | 0.12% |
| TFS CAPITAL LLC | 17,167 | $255,000 | 0.10% |
| FRANKLIN STREET ADVISORS INC /NC | 34,580 | $514,000 | 0.09% |